TCL Archive Advisors approve set-aside for alternative medicine “best case series.” November 19, 2004
TCL Archive Lilly drug Alimta misses the target, but wins ODAC endorsement for lung cancer. FDA’s Pazdur tells ODAC that decision on Alimta requires clinical judgment. July 30, 2004
